FDA halts decision of COVID-19 vaccine for children under 5

An FDA advisory panel was set to meet on Tuesday to decide on giving emergency approval to a COVID-19 vaccine for children under 5 developed by Pfizer, but too many questions have since arisen about how many doses would need to be administer among other issues.